Icatibant Acetate is the acetate salt form of icatibant, an antagonist of the human bradykinin B2 receptor (B2R), that can be used for the treatment of hereditary angioedema (HAE). Upon administration, icatibant targets and binds to B2R, thereby preventing bradykinin from binding to the B2R. This may prevent bradykinin/B2R-mediated vasodilation, the resulting increase in vascular permeability, and the swelling, inflammation, and pain associated with HAE. It is grouped under the following drug class(es): Bradykinin B2 receptor antagonists and Peptides. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include Hoechst 140 and Firazyr. Its PubChem CID is 6918172.
Icatibant acetate
| CAS No | 138614-30-9 |
|---|---|
| Molecular Formula | C61H93N19O15S |
| Molecular Weight | 1364.6 g/mol |
| Synonyms | (2S)-2-[[(2S,3aS,7aS)-1-[(3R)-2-[(2S)-2-[[(2S)-2-[[2-[[(2S,4R)-1-[(2S)-1-[(2S)-2-[[(2R)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]-4-hydroxypyrrolidine-2-carbonyl]amino]acetyl]amino]-3-thiophen-2-ylpropanoyl]amino]-3-hydroxypropanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid;acetic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Icatibant Acetate is the acetate salt form of icatibant, an antagonist of the human bradykinin B2 receptor (B2R), that can be used for the treatment of hereditary angioedema (HAE).
The listed CAS number is 138614-30-9.
The listed molecular formula is C61H93N19O15S.
The listed molecular weight is 1364.6 g/mol.
The source lists Hoechst 140 and Firazyr.
It is listed under Bradykinin B2 receptor antagonists and Peptides.